TSC2 and neoplasm: All 3 BLCA PDX models with TSC1/TSC2 deficiency were sensitive to RMC-5552, which caused significant tumor volume reduction in 2 of 3 PDX models, and delayed tumor growth in the third (Supplemental Figure 9, D–H).